Astrana Health, Inc. (ASTH) stock analysis
ASTH · Astrana Health, Inc.
Latest recorded price: USD 32.87
Model-estimated fair value: USD 15.62. This assumption-based estimate is for general research and is not investment advice.
Sector and industry: Healthcare · Medical Care Facilities
At $32.87, ASTH trades 110.4% above the model's base-case value of $15.62. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $9.02 in the conservative case and $23.93 in the optimistic case, with a valuation confidence score of 45/100. Fiscal 2025 figures: revenue growth 40.6%, free cash flow margin 3.3%, ROIC 4.7%. The model flags 1 risk signal for this company (1 high severity).